1st Department of Cardiology, Silesian Center for Heart Diseases, Zabrze, Medical University of Silesia, Katowice, Poland.
Cell Mol Biol Lett. 2007 Sep;12(3):331-47. doi: 10.2478/s11658-007-0006-1. Epub 2007 Feb 12.
Vascular endothelial growth factor (VEGF-A) is one of the most important proangiogenic factors. It has many isoforms encoded by one gene. The occurrence of these isoforms is associated with the process of alternative splicing of mRNA. Some of the splice forms are perceived as tissue specific. The aim of this study was to determine the alternative splicing of VEGF-A mRNA in dilated cardiomyopathy, especially at the level of particular myocardial layers. The assessment of post-transcriptional modifications of VEGF-A mRNA was made on specimens taken from the explanted hearts of patients undergoing cardiac transplantation. Molecular and histopathological studies were perfomed on particular layers of the myocardial muscle (endocardium, myocardium, epicardium). A molecular analysis of cardiac samples was performed by quantitative analysis of the mRNA of the studied VEGF-A isoforms (VEGF121,-145,-165,-183,-189, and-206) using QRTPCR with an ABI-PRISM 7700-TaqMan sequence detector. 72 cardiac specimens taken from the explanted hearts were analyzed. Each of the studied VEGF-A splice forms was present in the evaluated hearts, but the types of alternative splicing of mRNA were different in particular layers. Quantitative analysis revealed different amounts of the studied isoforms. Generally, significantly increased expression of the VEGF-A isoforms was observed in samples taken from hearts with post-inflammatory etiology of cardiomyopathy. Our conclusions are: 1. All the studied VEGF-A isoforms were found in the human hearts, including those thusfar considered characteristic for other tissues. 2. Significant differences were observed in the expression of the VEGF-A splice forms with respect to the myocardial layers and the location of the cardiac biopsy. 3. Repetitive and comparable results for samples with post-inflammatory etiology were obtained, and they revealed considerably higher amounts of VEGF-A isoforms compared to specimens with idiopathic etiology.
血管内皮生长因子 (VEGF-A) 是最重要的促血管生成因子之一。它由一个基因编码多种同工型。这些同工型的发生与 mRNA 的选择性剪接过程有关。一些剪接形式被认为是组织特异性的。本研究旨在确定扩张型心肌病中 VEGF-A mRNA 的选择性剪接,特别是在特定心肌层的水平。VEGF-A mRNA 转录后修饰的评估是在接受心脏移植的患者心脏移植标本上进行的。对心肌的特定层(心内膜、心肌、心外膜)进行了分子和组织病理学研究。通过使用 ABI-PRISM 7700-TaqMan 序列检测器进行 QRT-PCR 对研究的 VEGF-A 同工型 (VEGF121、-145、-165、-183、-189 和-206) 的 mRNA 进行定量分析,对心脏样本进行了分子分析。从心脏移植患者的心脏移植标本中分析了 72 个心脏标本。在所评估的心脏中均存在所研究的 VEGF-A 剪接形式,但特定层中 mRNA 的选择性剪接类型不同。定量分析显示研究的同工型的量不同。通常,在炎症后病因引起的心肌病的心脏样本中观察到 VEGF-A 同工型的表达显著增加。我们的结论是:1. 在人类心脏中发现了所有研究的 VEGF-A 同工型,包括迄今为止被认为是其他组织特征的同工型。2. 在 VEGF-A 剪接形式的表达方面观察到了心肌层和心脏活检位置的显著差异。3. 对炎症后病因的样本进行了重复且可比的结果,与特发性病因的标本相比,它们显示出相当高的 VEGF-A 同工型量。